Section VIII：Infant Nutrition——Session 2：Industrial Translation and Clinical Evidence |
2027-02-25 14:00-16:20 |
| 2027-02-25 14:00-14:20 From 'Simulation' to 'Evidence':Clinical Translation and Benefits of HMOs in Infant FormulaTBC |
| 2027-02-25 14:20-14:40 Clinical Study on Growth,Development,and Safety of Preterm Infant Formula in Preterm InfantsTBC |
| 2027-02-25 14:40-15:00 Clinical Practice and Challenges of Partially Hydrolyzed Protein FormulasTBC |
| 2027-02-25 15:00-15:20 Mixed Research Report on Effects of Different Feeding Methods on Allergy Prevention and Digestion-Absorption in InfantsTBC |
| 2027-02-25 15:20-15:40 Human Intervention Study of a Novel Strain:Probiotic Mechanisms and Evidence System for Infants and Young ChildrenSun Zhiping,Director,Nanjing Medical University |
| 2027-02-25 15:40-16:00 From Breast Milk Inspiration to Clinical Validation:The Evidence-Based Pathway for Infant Nutrition Innovation |
| 2027-02-25 16:00-16:20 Nutritional Characteristics and Quality of Demineralized Sheep Whey Powder from a Human Milk Mimicry PerspectiveGeneral Manager,Laiteries Triballat Noyal (France),China Region |
| 2027-02-25 16:20-16:40 Scientific Feeding Strategies for Infant Formula with Partially Hydrolyzed Dual ProteinXiong Hui,Dean,Mead Johnson Nutrition and Health Innovation Research Institute |
